Close Menu

Ghent University

Research institutions in the US and Europe will lead the studies, which will explore different aspects of COVID-19 such as host immune response.

Hatched from the computational genomics lab at Ghent University, BioLizard offers a small but complementary team to tackle AI and molecular pipeline challenges.

In Genome Biology this week: coding variants linked to cardiac conduction, comparison of two dozen differential gene expression analysis pipelines, and more.

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more

Researchers sequenced and analyzed the genome of Apostasia shenzhenica, which is part of a small sister lineage to other plants in the Orchidaceae family, uncovering new evolutionary clues.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

MDxHealth will use Ghent's methylation in situ hybridization technology to develop tests for urological cancers.

An international team has sequenced the Zostera marina genome to uncover gene gains and losses that helped it in its return to the sea.

NEW YORK (GenomeWeb) — Biogazelle said today that it has received a €2 million ($2.5 million) investment from Qbic Arkiv Fund, Foundation Majoie, and SOFI (Spin-Off Financing Instrument).

NEW YORK (GenomeWeb) — Researchers interested in microRNA expression profiling today face a bevy of options including microarrays, quantitative PCR assays, and next-generation sequencing applications, but it is not always obvious which platform is the most suitable for a given study.

Pages

Novamax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.